Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD

被引：36
|
作者：
De, Arka [1 ]
Bhagat, Naveen [1 ]
Mehta, Manu [1 ]
Taneja, Sunil [1 ]
Duseja, Ajay [1 ,2 ]
机构：
[1] Postgrad Inst Med Educ & Res, Dept Hepatol, Chandigarh, India
[2] Post Grad Inst Med Educ & Res, Dept Hepatol, Chandigarh 160012, India
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷 / 02期
关键词：
D O I：
10.1016/j.jhep.2023.07.031
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：e61 / e62
页数：2
相关论文
共 50 条
  • [21] Metabolic dysfunction-associated steatotic liver disease and atherosclerosis
    Castillo-Nunez, Yulino
    Almeda-Valdes, Paloma
    Gonzalez-Galvez, Guillermo
    Arechavaleta-Granell, Maria del Rosario
    [J]. CURRENT DIABETES REPORTS, 2024, 24 (07) : 158 - 166
  • [22] Menopause and metabolic dysfunction-associated steatotic liver disease
    Polyzos, Stergios A.
    Goulis, Dimitrios G.
    [J]. MATURITAS, 2024, 186
  • [23] Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents
    Maldonado-Rojas, Andrea del Carmen
    Zuarth-Vazquez, Julia Maria
    Uribe, Misael
    Barbero-Becerra, Varenka J.
    [J]. ANNALS OF HEPATOLOGY, 2024, 29 (02)
  • [24] Implications of Protein and Sarcopenia in the Prognosis, Treatment, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Singh, Avneet
    Buckholz, Adam
    Kumar, Sonal
    Newberry, Carolyn
    [J]. NUTRIENTS, 2024, 16 (05)
  • [25] The Role of Endoplasmic Reticulum in Lipotoxicity during Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Pathogenesis
    Venkatesan, Nanditha
    Doskey, Luke C.
    Malhi, Harmeet
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2023, 193 (12): : 1887 - 1899
  • [26] Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases
    Sandireddy, Reddemma
    Sakthivel, Suganya
    Gupta, Priyanka
    Behari, Jatin
    Tripathi, Madhulika
    Singh, Brijesh Kumar
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [27] New Therapeutic Approaches for the Treatment of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Increased Cardiovascular Risk
    Brankovic, Marija
    Dukic, Marija
    Gmizic, Tijana
    Popadic, Viseslav
    Nikolic, Novica
    Sekulic, Ana
    Brajkovic, Milica
    Dokic, Jelena
    Mahmutovic, Edvin
    Lasica, Ratko
    Vojnovic, Marko
    Milovanovic, Tamara
    [J]. DIAGNOSTICS, 2024, 14 (02)
  • [28] Associating Appendicitis with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Novel Insight into an Unexpected Connection
    Roderburg, Christoph
    Waldschmidt, Dirk
    Leyh, Catherine
    Krieg, Sarah
    Krieg, Andreas
    Luedde, Tom
    Loosen, Sven H.
    Kostev, Karel
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
  • [29] The Lasting Effects of COVID-19 on the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Backer, Sean
    Khanna, Deepesh
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [30] Adipocytokines as Predictors of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Development in Type 2 Diabetes Mellitus Patients
    Fajkic, Almir
    Jahic, Rijad
    Hadzovic-Dzuvo, Almira
    Lepara, Orhan
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
12345